Plasma Cells

Plasma cells are terminally differentiated B lymphocytes that provide protective immunity through the continuous secretion of antibodies. Antibody-secreting cells develop in secondary lymphoid tissue following antigen stimulation and may enter a short-lived plasma cell population that reside primarily in the nonlymphoid area of the spleen or lymph nodes, or instead may migrate to the bone marrow where the majority enter a long-lived population of plasma cells.

Keywords: plasma cell; plasmablast; stromal cell; bone marrow; IL-6

Figure 1. Characteristic plasma cell morphology shown of bone marrow plasma cells stained with haematoxylin and eosin.
Figure 2. Maturation and migration of developing B cells. B cells develop from haematopoietic stem cells found in the periphery of the bone marrow. Differentiation progresses from the periphery of the marrow towards the central sinus. Development requires specific cytokines produced by and contact provided by stromal cells as indicated. Developing B cells are retained in the bone marrow (and restricted from early release) by chemokines produced primarily by stromal cells, namely CXCL12. Developing B cells express CXCR4, the receptor for CXCL12 on their surface. Once the immature B-cell stage is reached, the cells lose expression of CXCR4 and are released into the central sinus where they migrate to secondary lymphoid tissue. Plasmablasts entering the bone marrow from the secondary lymphoid tissue similarly find stromal cells to support their longevity. Again, stromal cells provide soluble factors necessary for retention and survival in the marrow, such as IL-6 and CXCL12. While contact is needed for plasma cell survival, the adhesion event is unclear; however, VCAM-1 is dispensable.
Figure 3. Schematic of plasma cell development and resultant phenotype. Naive B cells stimulated with antigen form antibody-secreting, proliferation-capable plasmablasts. Provided with the appropriate cues, plasmablasts develop into terminally differentiated plasma cells. Plasma cells express Syndecan-1 (CD138), CD44 and VLA-4 on their surface (among others); they downregulate expression of MHC Class II, B220 and the BCR complex. Further, plasma cells express Blimp-1 and XBP-1, which results in the inhibition of proliferation and of Pax-5 expression, among others (see Figure 4).
Figure 4. A simplified model of the regulatory cascades initiated during plasma cell differentiation. Targets activated by a particular factor are indicated by arrows; targets repressed are indicated by bars.
Figure 5. A model of the elements necessary for maintaining plasma cell survival. Plasma cells and stromal cells interact in the bone marrow via VLA-4 on the plasma cell and an unknown ligand on the stromal cell. Contact induces the expression of IL-6 mRNA and consequently IL-6 secretion, which is critical to maintain plasma cell longevity. Further, stromal cells secrete CXCL12, which is important for attracting plasmablasts to the marrow, for retention of plasma cells in the marrow, and possibly for maintaining plasma cell survival.
close
 References
    Brieva JA, Roldan E, Rodriguez C and Navas G (1994) Human tonsil, blood and bone marrow in vivo-induced B cells capable of spontaneous and high-rate immunoglobulin secretion in vitro: differences in the requirements for factors and for adherent and bone marrow stromal cells, as well as distinctive adhesion molecule expression. European Journal of Immunology 24: 362–366.
    Calame KL, Lin K-I and Tunyaplin C (2003) Regulatory mechanisms that determine the development and function of plasma cells. Annual Review of Immunology 21: 205–230.
    Cassese G, Arce S, Hauser AE et al. (2003) Plasma cell survival is mediated by synergistic effects of cytokines and adhesion-dependent signals. Journal of Immunology 171: 1684–1690.
    Cyster JG (2003) Homing of antibody secreting cells. Immunological Reviews 194: 48–60.
    Dorshkind K (1990) Regulation of hemopoiesis by bone marrow stromal cells and their products. Annual Review of Immunology 8: 111–137.
    Kopf M, Baumann H, Freer G et al. (1994) Impaired immune and acute-phase responses in interleukin-6-deficient mice. Nature 368: 339–342.
    Ma Q, Jones D and Springer TA (1999) The chemokine receptor CXCR4 is required for the retention of B lineage and granulocytic precursors within the bone marrow microenvironment. Immunity 10: 463–471.
    Manz RA, Lohning M, Cassese G, Thiel A and Radbruch A (1998) Survival of long-lived plasma cells is independent of antigen. International Immunology 10: 1703–1711.
    Manz RA, Thiel A and Radbruch A (1997) Lifetime of plasma cells in the bone marrow [letter]. Nature 388: 133–134.
    McHeyzer-Williams MG (1997) Immune response decisions at the single cell level. Seminars in Immunology 9: 219–227.
    Medina F, Segundo C, Campos-Caro A, Gonzalez-Garcia I and Brieva JA (2002) The heterogeneity shown by human plasma cells from tonsil, blood, and bone marrow reveals graded stages of increasing maturity, but local profiles of adhesion molecule expression. Blood 99: 2154–2161.
    Merville P, Dechanet J, Grouard G, Durand I and Banchereau J (1995) T cell-induced B cell blasts differentiate into plasma cells when cultured on bone marrow stroma with IL-3 and IL-10. International Immunology 7: 635–643.
    Minges Wols HA, Underhill GH, Kansas GS and Witte PL (2002) The role of bone marrow-derived stromal cells in the maintenance of plasma cell longevity. Journal of Immunology 169: 4213–4221.
    Ochsenbein AF, Pinschewer DD, Sierro S et al. (2000) Protective long-term antibody memory by antigen-driven and T help-dependent differentiation of long-lived memory B cells to short-lived plasma cells independent of secondary lymphoid organs. Proceedings of the National Academy of Sciences of the USA 97: 13263–13268.
    O'Connor BP, Gleeson MW, Noelle RJ and Erickson LD (2003) The rise and fall of long-lived humoral immunity: terminal differentiation of plasma cells in health and disease. Immunological Reviews 194: 61–76.
    Osmond DG and Park YH (1987) B lymphocyte progenitors in mouse bone marrow. International Reviews in Immunology 2: 241–261.
    Rodriguez C, Roldan E, Navas G and Brieva JA (1993) Essential role of tumor necrosis factor-alpha in the differentiation of human tonsil in vivo induced B cells capable of spontaneous and high-rate immunoglobulin secretion. European Journal of Immunology 23: 1160–1164.
    Slifka MK, Antia R, Whitmire JK and Ahmed R (1998) Humoral immunity due to long-lived plasma cells. Immunity 8: 363–372.
 Further Reading
    Gass JN, Gunn KE, Sriburi R and Brewer JW (2004) Stressed-out B cells? Plasma-cell differentiation and the unfolded protein response. Trends in Immunology 25: 17–24.
    Iwakoshi NN, Lee AH, Vallabhajosyula P et al. (2003) Plasma cell differentiation and the unfolded protein response intersect at the transcription factor XBP-1. Nature Immunology 4: 321–329.
    Jelinek DF (1999) Mechanisms of myeloma cell growth control. Hematology/Oncology Clinics of North America 13: 1145–1157.
    Reimold AM, Etkin A, Clauss I et al. (2000) An essential role in liver development for transcription factor XBP-1. Genes and Development 14: 152–157.
    Tew JG, DiLosa RM, Burton GF et al. (1992) Germinal centers and antibody production in bone marrow. Immunological Reviews 126: 99–112.
    Turner CA Jr, Mack DH and Davis MM (1994) Blimp-1, a novel zinc finger-containing protein that can drive the maturation of B lymphocytes into immunoglobulin-secreting cells. Cell 77: 297–306.
Contact Editor close
Submit a note to the editor about this article by filling in the form below.

* Required Field

How to Cite close
Minges Wols, Heather A(Jan 2006) Plasma Cells. In: eLS. John Wiley & Sons Ltd, Chichester. http://www.els.net [doi: 10.1038/npg.els.0004030]